Company Statement: Pfizer receives approval from European Commission for pending acquisition of Wyeth
Extract: Pfizer Inc (NYSE: PFE) today announced that the European Commission (EC) has approved under the European Union (EU) Merger Regulation the company’s pending acquisition of Wyeth. The Commission's decision includes...To view the full article, register now.
Already a subscriber? Click here to view full article